Memory deficits seen in individuals with ‘long COVID’
Mar 29, 2022
Deficits increased with the severity of ongoing self-reported symptoms; the severity of initial illness did not influence later cognitive performance.
Prior statin use linked to reduced risk for death in COVID-19
Jul 21, 2021
The risk for death was significantly reduced with prior statin and/or antihypertensive use among those with a history of cardiovascular and/or hypertension.
Convalescent plasma unlikely to improve outcomes in severe COVID-19
Oct 14, 2021
The likelihood of improvement in organ support-free days is low in critically ill adults with COVID-19 receiving convalescent plasma.
COVID-19 infection risk drops with increasing immunity within family
Oct 13, 2021
Risk for COVID-19 infection progressively lower for nonimmune family members as number of family members with immunity increases
Two-thirds of survivors of the most severe COVID-19 face impairment at one year
Apr 26, 2024
Physical, psychiatric and cognitive problems were seen in those discharged to long-term acute care hospitals.
Burden of neurologic diagnoses lower after COVID-19 versus flu
Mar 20, 2024
Postinfection incident neurologic diagnoses were observed in 2.79 and 4.91% of the COVID-19 and influenza cohorts, respectively.
Cognitive symptoms common with post-COVID-19 condition
Feb 15, 2024
Symptoms were linked to increased odds of at least moderate interference with functioning and lower odds of full-time employment.
Unemployment benefit extension unlikely to start soon, despite Trump’s executive order
By
Amy Novotney
Aug 11, 2020
President Trump signed an executive order Saturday that seeks to partially extend the $600 per week federal unemployment benefits that expired July 31. The order calls for $400 a week in extra unemployment...
Most affordable seniors housing providers can’t afford pandemic supplies: survey
By
Amy Novotney
Oct 22, 2020
The majority (69%) of affordable seniors housing providers say they are at least financially strained — if not severely financially strained — as a result of having to pay for personal protective equipment,...
Severe COVID-19 rates low with monoclonal antibody therapy during delta surge
Jul 06, 2022
The rates of severe disease were low for high-risk patients with mild-to-moderate COVID-19 treated with antispike monoclonal antibodies.